Genui and SHS Capital to invest in ROTOP Pharmaka.

Genui, an investment company and SHS Capital, a private equity firm, agreed to invest in ROTOP Pharmaka, a pharmaceutical company specializing in the development, production, and distribution of radiopharmaceuticals used in nuclear medicine diagnostics. Financial terms were not disclosed.